Life expectancy hits 73.4 years and will reach 80, says WHO

October 22, 2021 Life expectancy has increased to 73.4 years, said the World Health Organisation (WHO) in a new report.

---

Trending now

Life expectancy hits 73.4 years and will reach 80, says WHO

Russia reports new COVID variant maybe more contagious than Delta, Putin declares non working days

---

Russia reports new COVID variant maybe more contagious than Delta, Putin declares non working days

October 21, 2021 Russia has reported some COVID-19 infections with a new coronavirus variant believed to be even more contagious than the Delta one, the RIA agency says.

BioVaxys files U.S. patent application for pan sarbecovirus vaccine

October 21, 2021 BioVaxys Technology announced that it has filed with the United States Patent and Trademark Office ("USPTO") a provisional patent application for its haptenized viral antigen vaccine platform to elicit a broad cross reactive immune response against most or all sarbecoviruses, the family of Coronaviruses that includes SARS-CoV-2, which causes Covid-19.

U.S. approves new booster of COVID-19 vaccines, 'mix and match' dose

October 21, 2021 The U.S. Food and Drug Administration (FDA) on Wednesday authorized COVID-19 booster doses of Moderna and Johnson and Johnson, and approved "mix and match" booster dose for currently available approved COVID-19 vaccines.

U.S. readies plan to vaccinate kids ages 5-11 against COVID-19

October 20, 2021 The Biden Administration is announcing a plan to ensure that, if a vaccine is authorized for children ages 5-11, it is quickly distributed and made conveniently and equitably available to families across the country.

Sahpra not to approve Sputnik V Covid-19 vaccine for use in South Africa

October 20, 2021 The Chairperson for Portfolio Committee on Health, Dr Kenneth Jacobs, has noted the South African Health Products Regulatory Authority’s (Sahpra’s) decision not to approve Russia’s Sputnik V Covid-19 vaccine for use in South Africa.

Immune Biosolutions begins Phase I clinical trial stages for its inhaled immunotherapy treatment

October 20, 2021 Québec based Immune Biosolutions announces the start of Phase I clinical trial for its immunotherapy (IBIO123) treatment, whose antibodies have the potential to neutralize and eliminate COVID-19 and its variants.

French study: Surgical masks still effective after 10 washes

October 19, 2021 Disposable surgical face masks that are usually considered to be single use maintain a high level of efficiency even after being washed up to 10 times, a new study by a consortium of French scientists has found.

Valneva says its COVID-19 vaccine triggers significantly stronger immune response

October 19, 2021 Valneva SE announced positive topline results from the Phase 3 pivotal trial Cov-Compare of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

EMA starts evaluating use of COVID-19 vaccine Comirnaty in children aged 5 to 11

October 19, 2021 EMA has started evaluating an application to extend the use of BioNTech/ fizer’s COVID-19 vaccine, Comirnaty, to children aged 5 to 11.